ChemoMetec A/S - Asset Resilience Ratio
ChemoMetec A/S (CHEMM) has an Asset Resilience Ratio of 0.40% as of June 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ChemoMetec A/S balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2020)
This chart shows how ChemoMetec A/S's Asset Resilience Ratio has changed over time. See ChemoMetec A/S (CHEMM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down ChemoMetec A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ChemoMetec A/S (CHEMM) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr1.04 Million | 0.4% |
| Total Liquid Assets | Dkr1.04 Million | 0.40% |
Asset Resilience Insights
- Limited Liquidity: ChemoMetec A/S maintains only 0.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ChemoMetec A/S Industry Peers by Asset Resilience Ratio
Compare ChemoMetec A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
MicroPort Endovascular MedTech Ltd
SHG:688016 |
Medical Devices | 18.30% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 12.10% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
Modular Medical Inc
NASDAQ:MODD |
Medical Devices | 16.40% |
Annual Asset Resilience Ratio for ChemoMetec A/S (2019–2020)
The table below shows the annual Asset Resilience Ratio data for ChemoMetec A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-06-30 | -35.65% | Dkr-93.81 Million ≈ $-14.68 Million |
Dkr263.12 Million ≈ $41.17 Million |
-1.00pp |
| 2019-06-30 | -34.66% | Dkr-82.55 Million ≈ $-12.92 Million |
Dkr238.22 Million ≈ $37.27 Million |
-- |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more